Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Abstract The value of adding induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) for the treatment of locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear. In our recent article entitled “Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chem...
Main Authors: | Wen-Fei Li, Lei Chen, Ying Sun, Jun Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | Chinese Journal of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-016-0157-4 |
Similar Items
-
Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study
by: Xia WX, et al.
Published: (2019-11-01) -
Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis
by: Bi-Cheng Wang, et al.
Published: (2022-07-01) -
Induction chemotherapy plus nimotuzumab followed
by concurrent chemoradiotherapy for advanced
nasopharyngeal carcinoma
by: Xinmao Song, et al.
Published: (2019-07-01) -
Survival after induction chemotherapy in locoregional advanced nasopharyngeal carcinoma: An updated systematic review and meta‐analysis
by: Yiyu Meng, et al.
Published: (2023-10-01) -
The Changing Role of Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Updated Systemic Review and Network Meta-Analysis
by: Mei Liu, et al.
Published: (2018-12-01)